A detailed history of Emerald Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Emerald Advisors, LLC holds 2,648 shares of ABBV stock, worth $501,663. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,648
Holding current value
$501,663
% of portfolio
0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$154.79 - $180.76 $409,883 - $478,652
2,648 New
2,648 $454,000
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $205,948 - $312,243
-3,193 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $230,311 - $288,168
3,193 New
3,193 $268,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $335B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Emerald Advisors, LLC Portfolio

Follow Emerald Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisors, LLC with notifications on news.